Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3
- PMID: 10811804
- DOI: 10.1074/jbc.M001515200
Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3
Abstract
Mitogen-activated protein (MAP) kinase phosphatase-3 (MKP-3) is a dual specificity phosphatase that inactivates extracellular signal-regulated kinase (ERK) MAP kinases. This reflects tight and specific binding between ERK and the MKP-3 amino terminus with consequent phosphatase activation and dephosphorylation of the bound MAP kinase. We have used a series of p38/ERK chimeric molecules to identify domains within ERK necessary for binding and catalytic activation of MKP-3. These studies demonstrate that ERK kinase subdomains V-XI are necessary and sufficient for binding and catalytic activation of MKP-3. These domains constitute the major COOH-terminal structural lobe of ERK. p38/ERK chimeras possessing these regions display increased sensitivity to inactivation by MKP-3. These data also reveal an overlap between ERK domains interacting with MKP-3 and those known to confer substrate specificity on the ERK MAP kinase. Consistent with this, we show that peptides representing docking sites within the target substrates Elk-1 and p90(rsk) inhibit ERK-dependent activation of MKP-3. In addition, abolition of ERK-dependent phosphatase activation following mutation of a putative kinase interaction motif (KIM) within the MKP-3 NH(2) terminus suggests that key sites of contact for the ERK COOH-terminal structural lobe include residues localized between the Cdc25 homology domains (CH2) found conserved between members of the DSP gene family.
Similar articles
-
Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.J Biol Chem. 2001 Aug 3;276(31):29440-9. doi: 10.1074/jbc.M103463200. Epub 2001 May 31. J Biol Chem. 2001. PMID: 11387337
-
The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity.J Biol Chem. 1998 Apr 10;273(15):9323-9. doi: 10.1074/jbc.273.15.9323. J Biol Chem. 1998. PMID: 9535927
-
Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.J Biol Chem. 2001 May 11;276(19):16491-500. doi: 10.1074/jbc.M010966200. Epub 2001 Jan 30. J Biol Chem. 2001. PMID: 11278799
-
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.Curr Opin Cell Biol. 2000 Apr;12(2):186-92. doi: 10.1016/s0955-0674(99)00075-7. Curr Opin Cell Biol. 2000. PMID: 10712927 Review.
-
Mitogen activated protein kinase phosphatases and cancer.Cancer Biol Ther. 2010 Mar 1;9(5):337-40. doi: 10.4161/cbt.9.5.11217. Epub 2010 Mar 17. Cancer Biol Ther. 2010. PMID: 20139719 Free PMC article. Review.
Cited by
-
Development of extracellular signal-regulated kinase inhibitors.Curr Top Med Chem. 2009;9(8):678-89. doi: 10.2174/156802609789044416. Curr Top Med Chem. 2009. PMID: 19689374 Free PMC article. Review.
-
Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.Mol Cell Biol. 2003 Jul;23(14):4796-804. doi: 10.1128/MCB.23.14.4796-4804.2003. Mol Cell Biol. 2003. PMID: 12832467 Free PMC article.
-
Biology using engineering tools: the negative feedback amplifier.Cell Cycle. 2011 Jul 1;10(13):2069-76. doi: 10.4161/cc.10.13.16245. Epub 2011 Jul 1. Cell Cycle. 2011. PMID: 21572255 Free PMC article.
-
Oxidative stress, inflammation, and cancer: how are they linked?Free Radic Biol Med. 2010 Dec 1;49(11):1603-16. doi: 10.1016/j.freeradbiomed.2010.09.006. Epub 2010 Sep 16. Free Radic Biol Med. 2010. PMID: 20840865 Free PMC article. Review.
-
Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure.Bioorg Med Chem Lett. 2006 Dec 15;16(24):6281-7. doi: 10.1016/j.bmcl.2006.09.038. Epub 2006 Sep 26. Bioorg Med Chem Lett. 2006. PMID: 17000106 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous